Validating performance of an Agilent ICP‑MS for USP <232>/<233> & ICH Q3D(R2)/Q2(R1)
Aplikace | 2022 | Agilent TechnologiesInstrumentace
ICP/MS
ZaměřeníFarmaceutická analýza
VýrobceAgilent Technologies
Klíčová slovapde, elemental, pharmaceutical, elements, icp, spike, element, pdes, ich, mean, procedures, impurities, day, limits, polyatomic, oral, validation, subtraction, concentrations, drift, unspiked, chapters, sample, used, reported, hypromellose, measured, usp, inhalational, suitability, after, may, isotopes, ionized, procedure, interferences, result, add, samples, unequivocally, acceptance, dilution, lower, parenteral, becs, quantitative, measuring, also, pharmaceuticals, uhmi
Podobná PDF
Analysis of Artificial Tear Eye Drops For Elemental Impurities
2022|Agilent Technologies|Aplikace
Application Note Pharma & Biopharma Analysis of Artificial Tear Eye Drops For Elemental Impurities Using an ICP-MS and USP <232>/<233> and ICH Q3D(R2)/Q2(R1) protocols. Authors Jennifer Sanderson and Lindsey Whitecotton Agilent Technologies, Inc. Introduction As pharmaceutical products are released to…
Klíčová slova
pde, pdeppb, ppbday, dayratio, ratioelement, elementconcentration, concentrationtear, tearelemental, elementalelements, elementsdaily, dailyeye, eyedrops, dropsruggedness, ruggednesssuitability, suitabilityartificial
Validating the Agilent 7700x/7800 ICP-MS for the determination of elemental impurities in pharmaceutical ingredients according to draft USP general chapters <232>/<233>
2015|Agilent Technologies|Aplikace
Validating the Agilent 7700x/7800 ICP-MS for the determination of elemental impurities in pharmaceutical ingredients according to draft USP general chapters <232>/<233> Application note Pharmaceutical Authors Samina Hussain Exova USA Amir Liba and Ed McCurdy Agilent Technologies USA Abstract The United…
Klíčová slova
pharmaceutical, pharmaceuticalppb, ppbelements, elementsvalidation, validationelement, elementicp, icpprocedures, procedurespde, pdeelemental, elementalgelcap, gelcaprsd, rsdmean, meanlimit, limitdose, dosesuitability
Analysis of Elemental Impurities in Synthetic Oligonucleotides by ICP-MS
2023|Agilent Technologies|Aplikace
Application Note Biopharma Analysis of Elemental Impurities in Synthetic Oligonucleotides by ICP-MS Development and testing of an efficient Agilent 7850 ICP-MS method in compliance with USP <232>/<233> and ICH Q3D(R2)/Q2(R1) Authors Introduction Bian Yulan and Li Shuping Synthetic oligonucleotides are…
Klíčová slova
oligonucleotides, oligonucleotideselemental, elementalich, icholigonucleotide, oligonucleotideusp, usppdes, pdesprocedures, proceduresicp, icpimpurities, impuritieselement, elementparenteral, parenteralprecision, precisionmust, mustguidelines, guidelinessynthetic
Determining Elemental Impurities in Pharmaceutical Ingredients using ICP-MS
2021|Agilent Technologies|Aplikace
Application Note Pharmaceuticals Determining Elemental Impurities in Pharmaceutical Ingredients using ICP-MS USP/ICH methodology used to measure 24 elemental impurities in raw materials dissolved in DMSO Authors Radhey S. Dhuria, Vinay Jain, Gaurav Kapadnis and Samir Vyas Agilent Technologies, Inc. Introduction…
Klíčová slova
pharmaceutical, pharmaceuticalimpurities, impuritieselement, elementelemental, elementalusp, uspstandardization, standardizationdmso, dmsoingredients, ingredientsvalue, valueicp, icpich, ichgas, gasorganic, organicmicrowave, microwaveclosed